Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Lori R. Armstrong"'
Autor:
Rachel M. Wells, Joni Young, R. Joel Williams, Lori R. Armstrong, Kristi Busico, Ali S. Khan, Thomas G. Ksiazek, Pierre E. Rollin, Sherif R. Zaki, Stuart T. Nichol, C.J. Peters
Publikováno v:
Emerging Infectious Diseases, Vol 3, Iss 3, Pp 361-365 (1997)
In 1996, investigation of a hantavirus pulmonary syndrome (HPS) outbreak in southern Argentina found evidence of person-to-person transmission of a hantavirus. The infection control ramifications of this finding led to this review of hantavirus epide
Externí odkaz:
https://doaj.org/article/29dbcc2e233a44ada6ebd89d99a07ed8
Autor:
Charles F. Fulhorst, Mary Louise Milazzo, Lori R. Armstrong, James E. Childs, Pierre E. Rollin, Rima Khabbaz, C.J. Peters, Thomas G. Ksiazek
Publikováno v:
Emerging Infectious Diseases, Vol 13, Iss 4, Pp 532-532 (2007)
Rodents are the principal hosts of Sin Nombre virus, 4 other hantaviruses known to cause hantavirus pulmonary syndrome in North America, and the 3 North American arenaviruses. Serum samples from 757 persons who had worked with rodents in North Americ
Externí odkaz:
https://doaj.org/article/936e4e860a2249ef90bacb2db7554be9
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
Introduction To describe diabetes trends among adults with incident tuberculosis (TB) disease and examine diabetes-associated TB characteristics and patient outcomes in the USA.Research design and methods We examined all 71 855 persons aged ≥20 yea
Externí odkaz:
https://doaj.org/article/cd0de3184ea94a8c9042c098fbbac1d8
Autor:
Lori R. Armstrong, Rongxia Li, Varsha Kumar, Amy N. Whitesell, Angela M. Starks, Tracy Dalton
Publikováno v:
Open Forum Infect Dis
Background Nucleic acid amplification (NAA) tests rapidly detect Mycobacterium tuberculosis complex directly from clinical specimens, providing valuable results for those evaluated for tuberculosis. Methods We analyzed characteristics of cases with N
Autor:
Jefferson M. Jones, Lori R. Armstrong
Publikováno v:
Public Health Reports. 132:480-487
Objectives: Drug-susceptibility testing (DST) of Mycobacterium tuberculosis is necessary for identifying drug-resistant tuberculosis, administering effective treatment regimens, and preventing the spread of drug-resistant tuberculosis. DST is recomme
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report
The majority of tuberculosis (TB) cases in the United States are attributable to reactivation of latent TB infection (LTBI) (1). LTBI refers to the condition when a person is infected with Mycobacterium tuberculosis without signs and symptoms, or rad
Autor:
Lauren A. Lambert, Lori R. Armstrong, Mark N. Lobato, Christine Ho, Anne Marie France, Maryam B. Haddad
Publikováno v:
American Journal of Public Health. 106:2231-2237
Objectives. To describe cases and estimate the annual incidence of tuberculosis in correctional facilities. Methods. We analyzed 2002 to 2013 National Tuberculosis Surveillance System case reports to characterize individuals who were employed or inca
Publikováno v:
J Public Health Manag Pract
Context Resistance to isoniazid (INH) only (monoresistance), with drug susceptibility to rifampin, pyrazinamide, and ethambutol at diagnosis of tuberculosis (TB) disease, can increase the length of treatment. Objective To describe US trends in INH mo
Publikováno v:
Clin Infect Dis
Background In 2016, the World Health Organization (WHO) recommended a shorter (9–12 month) multidrug-resistant tuberculosis (MDR-TB) treatment regimen (as compared to the conventional 18–24 month regimen) for patients without extrapulmonary TB, p
Autor:
Lori R. Armstrong, Barbara H. Bardenheier, Carla A. Winston, Thomas R. Navin, Shareen A Iqbal
Objectives. To assess changes in US tuberculosis (TB) incidence rates by age, period, and cohort effects, stratified according to race/ethnicity and nativity. Methods. We used US National Tuberculosis Surveillance System data for 1996 to 2016 to esti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f84761ef71d1edb741002dc9c66b30
https://europepmc.org/articles/PMC6215379/
https://europepmc.org/articles/PMC6215379/